Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-353,877	Closed	-$12M	–	21
2021 Q3	$12M	Buy	353,877 +2,380	+0.7%	+$76K	3.45%	12
2021 Q2	$12.9M	Buy	351,497 +2,877	+0.8%	+$111K	3.61%	12
2021 Q1	$15.6M	Buy	348,620 +3,225	+0.9%	+$150K	4.68%	9
2020 Q4	$19.7M	Buy	345,395 +1,369	+0.4%	+$81.1K	8.84%	5
2020 Q3	$17.6M	Buy	344,026 +2,692	+0.8%	+$132K	9.59%	5
2020 Q2	$20.4M	Buy	341,334 +2,616	+0.8%	+$140K	12%	2
2020 Q1	$13.9M	Buy	338,718 +232,851	+220%	+$12.9M	15.33%	3
2019 Q4	$6.59M	Buy	+105,867	New	+$5.03M	5.75%	8

Other funds holding DCPH

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's DCPH Position: Q4 2021 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 353,877 shares — an estimated $12M sold.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in DCPH in Q4 2019 and held it in 8 quarters. The position peaked at $20.4M in Q2 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 353,877 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $12M.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $20.4M in Q2 2020.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q4 2021, filed 17 May 2024.